Disc Medicine, Inc. (IRON) stock
IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$76.57−0.02 (-0.03%)
Close on Nov 17, 2026Market cap $2.94BP/E –Yield –
Disc Medicine cash
Cash and short-term investments held at the end of each period.
Disc Medicine's cash was $717.70M at Jun 30, 2026. For fiscal 2025 it was $791.20M, up 61.5% from the year before. The highest annual figure on record is $791.20M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $791.20M | +61.5% |
| FY2024 | Dec 31, 2024 | $489.90M | +35.9% |
| FY2023 | Dec 31, 2023 | $360.62M | +85.1% |
| FY2022 | Dec 31, 2022 | $194.79M | +120.8% |
| FY2021 | Dec 31, 2021 | $88.21M | +240.8% |
| FY2020 | Dec 31, 2020 | $25.89M | +682.3% |
| FY2019 | Dec 31, 2019 | $3.31M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $717.70M | +10.4% |
| Q1 FY2026 | Mar 31, 2026 | $730.20M | +5.1% |
| Q4 FY2025 | Dec 31, 2025 | $791.20M | +61.5% |
| Q3 FY2025 | Sep 30, 2025 | $615.90M | +26.4% |
| Q2 FY2025 | Jun 30, 2025 | $650.00M | +29.8% |
| Q1 FY2025 | Mar 31, 2025 | $694.70M | +102.6% |
| Q4 FY2024 | Dec 31, 2024 | $489.90M | +35.9% |
| Q3 FY2024 | Sep 30, 2024 | $487.40M | +31.5% |
| Q2 FY2024 | Jun 30, 2024 | $500.90M | +32.6% |
| Q1 FY2024 | Mar 31, 2024 | $342.85M | +44.9% |
| Q4 FY2023 | Dec 31, 2023 | $360.62M | +85.1% |
| Q3 FY2023 | Sep 30, 2023 | $370.66M | +566.1% |
| Q2 FY2023 | Jun 30, 2023 | $377.72M | +478.1% |
| Q1 FY2023 | Mar 31, 2023 | $236.60M | +217.7% |
| Q4 FY2022 | Dec 31, 2022 | $194.79M | +120.8% |
| Q3 FY2022 | Sep 30, 2022 | $55.65M | -63.0% |
| Q2 FY2022 | Jun 30, 2022 | $65.34M | -61.1% |
| Q1 FY2022 | Mar 31, 2022 | $74.47M | -59.8% |
| Q4 FY2021 | Dec 31, 2021 | $88.21M | +240.8% |
| Q3 FY2021 | Sep 30, 2021 | $150.39M | +1010.9% |
| Q2 FY2021 | Jun 30, 2021 | $167.80M | +2482.3% |
| Q1 FY2021 | Mar 31, 2021 | $185.31M | +1270.4% |
| Q4 FY2020 | Dec 31, 2020 | $25.89M | +682.3% |
| Q3 FY2020 | Sep 30, 2020 | $13.54M | – |
| Q2 FY2020 | Jun 30, 2020 | $6.50M | – |
| Q1 FY2020 | Mar 31, 2020 | $13.52M | – |
| Q4 FY2019 | Dec 31, 2019 | $3.31M | – |
See a number that looks wrong?